We are proud to have been involved in the Rewriting Cancer series, produced for UICC by BBC StoryWorks in 2024. This series is separated into three parts: Changing the Odds, Changing the Outcome, and Changing the Experience. Aiming to dispel myths, highlight advancements in cancer diagnosis, prevention, and treatment, Rewriting Cancer examines real life experiences of people living with cancer.
“That trial afforded me a really, really beautiful year of living.”
Ellipses Pharma features in part one, Changing the Odds: Pairing experience with expertise – how listening could accelerate cancer treatment, which follows the story of Nina, who is living with stage four breast cancer. Nina tells her story of how participating in clinical trials offered her a different quality of life. Nina is a passionate advocate for clinical trials to be considered as a treatment line rather than a “last chance” if they run out of licensed drugs.
Professor Tobias Arkenau, Global Head of Drug Development and Chief Medical Officer at Ellipses Pharma, discusses how we are disrupting the clinical trials process to accelerate the development of new cancer treatments.